| |
| |
|
| Insider
Information: |
Winningham Rick E |
| Relationship: |
|
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
2,686,408 |
|
|
Indirect Shares
|
96,467 |
|
|
| Direct
Value |
$32,443,553 |
|
|
|
Indirect Value
|
$950,200 |
|
|
| Total
Shares |
2,782,875 |
|
|
| Total
Value |
$33,393,753 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -15.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Innoviva Inc |
INVA |
Director |
2014-08-15 |
825,391 |
2008-01-29 |
0 |
Premium* |
|
|
Jazz Pharmaceuticals Inc |
JAZZ |
Director |
2023-08-14 |
10,444 |
2012-01-11 |
0 |
Premium* |
|
|
Theravance Biopharma, Inc. |
TBPH |
|
2024-04-02 |
1,850,573 |
2024-04-02 |
96,467 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
130 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
• • – |
2018-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
28,000 |
894,377 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
• • – |
2018-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
105,000 |
987,237 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2018-08-09 |
4 |
A |
$0.00 |
$0 |
D/D |
1,495 |
12,589 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
• • – |
2019-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
317,000 |
1,112,939 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2019-08-08 |
4 |
A |
$0.00 |
$0 |
D/D |
1,920 |
5,150 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
• • – |
2020-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
338,000 |
1,412,455 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2020-08-06 |
4 |
A |
$0.00 |
$0 |
D/D |
2,705 |
7,129 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
• • – |
2021-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
170,000 |
1,445,169 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2021-07-29 |
4 |
A |
$0.00 |
$0 |
D/D |
2,246 |
8,444 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
CHIEF EXECUTIVE OFFICER |
• • – |
2022-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
170,000 |
1,449,300 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2022-08-05 |
4 |
A |
$0.00 |
$0 |
D/D |
2,561 |
9,699 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
CHIEF EXECUTIVE OFFICER |
• • – |
2022-12-13 |
4 |
GD |
$0.00 |
$0 |
D/D |
9,000 |
1,400,797 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
CHIEF EXECUTIVE OFFICER |
• • – |
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
330,000 |
1,643,377 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2023-08-11 |
4 |
A |
$0.00 |
$0 |
D/D |
3,075 |
11,685 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
CHIEF EXECUTIVE OFFICER |
• • – |
2024-03-15 |
4 |
GD |
$0.00 |
$0 |
D/D |
10,900 |
1,550,573 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
CHIEF EXECUTIVE OFFICER |
• • – |
2024-03-15 |
4 |
GA |
$0.00 |
$0 |
I/I |
3,900 |
3,900 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
CHIEF EXECUTIVE OFFICER |
• • – |
2024-04-02 |
4 |
A |
$0.00 |
$0 |
D/D |
300,000 |
1,850,573 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
CHIEF EXECUTIVE OFFICER |
• • – |
2024-03-15 |
4 |
A |
$8.64 |
$23,363 |
D/D |
2,704 |
1,561,473 |
0 |
- |
|
| INVA |
Innoviva Inc |
Chief Executive Officer |
• • – |
2010-02-20 |
4 |
D |
$10.22 |
$24,661 |
D/D |
(2,413) |
166,627 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
• • – |
2015-02-20 |
4 |
D |
$19.52 |
$28,890 |
D/D |
(1,480) |
520,158 |
0 |
- |
|
| INVA |
Innoviva Inc |
Chief Executive Officer |
• • – |
2009-02-20 |
4 |
D |
$14.87 |
$31,346 |
D/D |
(2,108) |
41,010 |
0 |
- |
|
| INVA |
Innoviva Inc |
Chief Executive Officer |
• • – |
2009-05-20 |
4 |
D |
$14.06 |
$32,380 |
D/D |
(2,303) |
118,707 |
0 |
- |
|
| INVA |
Innoviva Inc |
Chief Executive Officer |
• • – |
2009-11-20 |
4 |
D |
$14.04 |
$33,191 |
D/D |
(2,364) |
114,040 |
0 |
- |
|
| INVA |
Innoviva Inc |
Chief Executive Officer |
• • – |
2010-05-20 |
4 |
D |
$13.02 |
$47,198 |
D/D |
(3,625) |
163,002 |
0 |
- |
|
| INVA |
Innoviva Inc |
Chief Executive Officer |
• • – |
2010-08-20 |
4 |
D |
$14.00 |
$50,736 |
D/D |
(3,624) |
159,378 |
0 |
- |
|
130 Records found
|
|
Page 2 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
